Laparoscopic cholecystectomy. Disease of gallbladder, unspecified
Conditions
Interventions
Intervention 1: Intervention group1: group A patients
will receive 10 ml of ropivacaine 0.5% (Made by the company Fresenius Kabi, Austria) in the areas below the right and left diaphragm and in the gallbladder bed. Intervention 2: Intervention group2:
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Informed consent People aged 18 to 60 are eligible candidates for laparoscopic cholecystectomy surgery
Exclusion criteria
Exclusion criteria: History of heart diseases Hypertension Bradycardia Simultaneous presence of peripheral neuropathy pregnant women Patients who are addicted to drugs and stimulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain. Timepoint: Times 0-1-2-4-8-12 and 24 hours after the operation. Method of measurement: VAS (Visual Analog Scale) & VRS(Verbal Rating Scale) numerical scoring scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAsghar Rayat zade
Shiraz University of Medical Sciences
Outcome results
None listed